This course generates understanding of the range of activities that take a new candidate drug molecule through Development, Manufacturing and Commercialization to routine patient use.

It is a highly interactive, clearly explained journey through:

• Technical development – making the molecule and the medicine
• Preclinical safety – ensuring drugs are safe enough for patient use
• Early clinical trials – evaluating viability of new drugs
• Integrating healthcare with digital support and advanced diagnostics
• Major trials and Regulatory – proving value and seeking license to market
• Branding and commercialization for launch
• Manufacturing and supply chain set up
• Getting new treatments to patients worldwide

Who Should Attend?

Those who will benefit from an understanding of what is done to bring new treatments from the end of the target/drug discovery stage, all the way to patient use. This is helpful (for example) for:

• Scientific and technical staff whose organisations may aspire to build their businesses to later stages of development.
• Service function staff who need to operate better knowing the 'language' of their internal customers.
• BioPharma service companies' staff who need to better understand clients' business.